Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey

J Neural Transm Suppl. 1998:52:279-85. doi: 10.1007/978-3-7091-6499-0_28.

Abstract

Striatal extracellular fluid concentrations of dopamine and metabolites in response to direct striatal administration of two L-DOPA boluses administered sequentially were determined in three rhesus monkeys during halothane anesthesia. Whereas in an initial microdialysis run, generation of dopamine was less following the second L-DOPA bolus than the first, in a subsequent run, in which the selective MAO-B inhibitor R(+)-N-propargyl-1-aminoindan (rasagiline) was administered systemically (0.2 mg/kg s.c.) between the two L-DOPA boluses, generation of dopamine was greater following the second bolus.

MeSH terms

  • 3,4-Dihydroxyphenylacetic Acid / metabolism
  • Animals
  • Caudate Nucleus / drug effects
  • Caudate Nucleus / metabolism*
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism*
  • Dopamine / metabolism*
  • Homovanillic Acid / metabolism
  • Indans / pharmacology*
  • Isoenzymes / antagonists & inhibitors*
  • Levodopa / metabolism*
  • Macaca mulatta
  • Microdialysis
  • Monoamine Oxidase / metabolism*
  • Monoamine Oxidase Inhibitors / pharmacology*

Substances

  • Indans
  • Isoenzymes
  • Monoamine Oxidase Inhibitors
  • rasagiline
  • 3,4-Dihydroxyphenylacetic Acid
  • Levodopa
  • Monoamine Oxidase
  • Dopamine
  • Homovanillic Acid